Proangiogenic characteristics of activated macrophages from patients with age-related macular degeneration

Shira Hagbi-Levi1, Michelle Grunin1, Tareq Jaouni1

  • 1Department of Ophthalmology, Hadassah-Hebrew University Medical Center and the Hebrew University-Hadassah School of Medicine, Jerusalem, Israel.

Neurobiology of Aging
|January 1, 2017
PubMed

Insights

Activated macrophages, especially M(IFNγ and LPS) types from patients with neovascular age-related macular degeneration (nvAMD), promote blood vessel growth. This suggests these specific macrophages could be therapeutic targets for treating nvAMD.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Macrophages are implicated in neovascular age-related macular degeneration (nvAMD) pathogenesis.
  • The specific macrophage phenotype associated with nvAMD and their pathogenic potential remain unclear.

Purpose of the Study:

  • To evaluate macrophages derived from peripheral blood monocytes of nvAMD patients and controls.
  • To assess macrophage expression profiles and angiogenic potential.

Main Methods:

  • Polarization of macrophages into classic (M[IFNγ and LPS]) and alternative (M[IL-4 and IL-13]) phenotypes.
  • Assessment of gene and protein expression profiles.
  • Evaluation of angiogenic potential using choroid sprouting assay and a rat model of laser-induced choroidal neovascularization.

Main Results:

  • Both classic and alternative polarized macrophages exhibited proangiogenic and inflammatory gene/protein profiles.
  • Activated macrophages, particularly M(IFNγ and LPS) phenotype from nvAMD patients, demonstrated proangiogenic effects ex vivo and in vivo.

Conclusions:

  • Activated human macrophages, especially M(IFNγ and LPS) phenotype from nvAMD patients, are implicated in nvAMD pathogenesis.
  • Further research is needed to explore activated macrophages as potential therapeutic targets for nvAMD.